2-151646139-GTTGA-G
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001164507.2(NEB):c.7523_7526delTCAA(p.Ile2508ThrfsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000151 in 1,586,504 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001164507.2 frameshift
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NEB | NM_001164507.2 | c.7523_7526delTCAA | p.Ile2508ThrfsTer14 | frameshift_variant | Exon 55 of 182 | ENST00000427231.7 | NP_001157979.2 | |
| NEB | NM_001164508.2 | c.7523_7526delTCAA | p.Ile2508ThrfsTer14 | frameshift_variant | Exon 55 of 182 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.7523_7526delTCAA | p.Ile2508ThrfsTer14 | frameshift_variant | Exon 55 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
| NEB | ENST00000427231.7 | c.7523_7526delTCAA | p.Ile2508ThrfsTer14 | frameshift_variant | Exon 55 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
| NEB | ENST00000409198.5 | c.7523_7526delTCAA | p.Ile2508ThrfsTer14 | frameshift_variant | Exon 55 of 150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000186 AC: 4AN: 214972 AF XY: 0.0000261 show subpopulations
GnomAD4 exome AF: 0.0000160 AC: 23AN: 1434296Hom.: 0 AF XY: 0.0000197 AC XY: 14AN XY: 710900 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:2
This sequence change creates a premature translational stop signal (p.Ile2508Thrfs*14) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is present in population databases (no rsID available, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with nemaline myopathy (PMID: 16917880). This variant is also known as g.87012_87015del. ClinVar contains an entry for this variant (Variation ID: 242434). For these reasons, this variant has been classified as Pathogenic.
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
NEB-related disorder Pathogenic:1
The NEB c.7523_7526delTCAA variant is predicted to result in a frameshift and premature protein termination (p.Ile2508Thrfs*14). In the literature, this variant is also referred to as g.87012_87015delAATC. This variant has been reported in the compound heterozygous state in individuals with nemaline myopathy (Family 41, mild form of disease, Lehtokari et al. 2006. PubMed ID: 16917880; #17, Punetha et al. 2016. PubMed ID: 27854218). This variant was also reported in the heterozygous state in an induvial with nemaline myopathy (Family 19, Todd et al. 2015. PubMed ID: 26578207). This variant is reported in 0.0042% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-152502653-GTTGA-G). Frameshift variants in NEB are expected to be pathogenic. This variant is interpreted as pathogenic.
not provided Pathogenic:1
The c.7523_7526delTCAA pathogenic variant in the NEB gene has been reported previously using alternate nomenclature (g.87012_87015delAATC) in combination with another NEB variant in an individual with a mild form of nemaline myopathy (Lehtokari et al., 2006). The c.7523_7526delTCAA variant causes a frameshift starting with codon Isoleucine 2508, changes this amino acid to a Threonine residue, and creates a premature Stop codon at position 14 of the new reading frame, denoted p.Ile2508ThrfsX14. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The c.7523_7526delTCAA variant was not observed in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.7523_7526delTCAA as a pathogenic variant.
Arthrogryposis multiplex congenita 6 Pathogenic:1
Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at